
Mineralys Therapeutics, Inc. (NASDAQ:MLYS) Q1 2025 Earnings Call Transcript
Mineralys Therapeutics, Inc. (NASDAQ:MLYS) Q1 2025 Earnings Call Transcript May 12, 2025 Mineralys Therapeutics, Inc. beats earnings expectations. Reported EPS is $-0.79, expectations were $-1.02. Dan Ferry – LifeSci Advisors, IR: Jon Congleton – CEO: Dave …